WuXi NextCODE has acquired Genomics Medicine Ireland (GMI), as part of a wider $70m initiative aimed at promoting Ireland as a global hub for genomic research and advanced life sciences. The Ireland Strategic Investment Fund has contributed $400m to the investment, while other investors include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital. Financial terms of the GMI acquisition were not announced.
WuXi NextCODE has acquired Genomics Medicine Ireland (GMI), as part of a wider $400m initiative aimed at promoting Ireland as a global hub for genomic research and advanced life sciences. The Ireland Strategic Investment Fund has contributed $70m to the investment, while other investors include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital. Financial terms of the GMI acquisition were not announced.